<DOC>
	<DOCNO>NCT01715922</DOCNO>
	<brief_summary>The aim trial demonstrate sub-Saharan African setting , association : 1 . Oral treatment : high dose fluconazole ( 1600mg/d ) associate flucytosine ( 100 mg/kg/j ) induction therapy 2. lumbar puncture control intracranial pressure decrease mortality rate 35 % 10 week . This non-randomized open label pilot study , standardized management cryptococcoses meningitis follow-up Burundi Ivory Coast . A total 41 patient enrol .</brief_summary>
	<brief_title>Study Evaluating Efficiency Tolerance High-dose Fluconazole Associated With Flucytosine Induction Therapy Cryptococcal Meningitis Associated With HIV Sub-saharan Africa</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis , Cryptococcal</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<mesh_term>Flucytosine</mesh_term>
	<criteria>&gt; 18 year HIV Infection First episode cryptococcal meningitis basis CSF India ink and/or CSF cryptococcal antigen . Glasgow &gt; 9 lumbar puncture Absence peripheral focal deficit limb inform consent sign Hemoglobin &lt; 7.5 g / dl ; neutrophil count &lt; 500/mm3 ; Platelets count &lt; 50 000/mm3 ; transaminase &gt; 5 time upper limit normal ; Troubles severe mental alertness Glasgow &lt; 9 initial lumbar puncture ; focal neurological deficit limb ; Pregnancy lactation go ; Ongoing systemic antifungal treatment ; History cryptococcal meningitis ; Ongoing rifampicin ritonavir treatment ; Subject participate another study risk mutual interference interpretation result .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Cryptococcal meningitis</keyword>
	<keyword>HIV Infections</keyword>
	<keyword>Oral treatment</keyword>
	<keyword>High dose fluconazole</keyword>
	<keyword>Flucytosine</keyword>
	<keyword>Burundi</keyword>
	<keyword>Ivory Coast</keyword>
</DOC>